Pre-market Hot Trades in US Stocks
Tilray is down 4.86% in pre-market trading. According to recent key news:
<ol>
<li>
On September 29, analysts rated Tilray as a hold, not included in the recommended buy list, leading to insufficient investor confidence and a drop in stock price. Source: MarketBeat.
</li>
<li>
On September 30, market rumors suggested that Trump might push for cannabis legalization. Although the news boosted market sentiment, it failed to effectively lift Tilray's stock price. Source: Market Rumors.
</li>
<li>
On September 28, investor preference shifted towards other cannabis companies like CRON and OGI, and Tilray failed to attract sufficient investment interest, putting pressure on its stock price. Source: Investor Comments. Changes in cannabis industry policies affect market sentiment.
</li>
</ol>
Top Gainers in Pre-market US Stocks
Sunrise New Energy is up 84.65% in pre-market trading. Based on recent important news:
<ol>
<li>
On September 29, Sunrise New Energy announced it had obtained a US patent related to the preparation method of lithium-ion battery anode materials. The granting of this patent drove the company's stock price up 178.1% in after-hours trading. Source: Company Announcement.
</li>
<li>
On September 26, Sunrise New Energy announced plans to build a 1GW lithium battery pack project in the US to meet the North American market's demand for energy storage batteries. This news boosted the company's stock price. Source: Company Announcement.
</li>
<li>
On September 26, technical indicators showed that despite some positive signals, the overbought RSI indicator warned investors to be cautious. Source: Technical Analysis Report. The demand for the new energy industry is growing, and market volatility is high.
</li>
</ol>
Vivakor is up 65.00% in pre-market trading. Based on recent important news:
<ol>
<li>On September 29, Vivakor announced it had signed a term sheet with a counterpart to provide up to $23 million in funding through the issuance of a new series of convertible preferred stock. This news significantly boosted the stock price.</li>
</ol>
SciSparc is up 55.83% in pre-market trading. According to recent key news:
<ol>
<li>
On September 29, SciSparc announced that its subsidiary MitoCareX would merge with N2OFF, focusing on drug discovery for drug-resistant cancers. This news drove SciSparc's stock price up 28.7% in after-hours trading.
</li>
<li>
On September 25, N2OFF shareholders approved the acquisition of MitoCareX, with transaction terms including a payment of $700,000 in cash and 40% of N2OFF's diluted shares to SciSparc. This transaction is expected to be completed in early October.
</li>
<li>
On September 29, SciSparc announced its latest progress in the treatment of central nervous system diseases, further enhancing market confidence. The industry is active in mergers and acquisitions, and market confidence is strengthening
</li>
</ol>

TLRY

FOFO

Tilray fell 4.86% in pre-market; Hang Feng Tech Innovation fell 4.66% in pre-market; Sunrise New Energy rose 84.65% in pre-market; Vivakor rose 65.00% in pre-market; SciSparc rose 55.83% in pre-market

Pre-market hot trades in US stocks: Tilray down 4.86% in pre-market; Hang Feng Tech Innovation down 4.66% in pre-market